Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Cash from Investing Activities (2020 - 2023)

Historic Cash from Investing Activities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $47.2 million.

  • Terns Pharmaceuticals' Cash from Investing Activities rose 42470.78% to $47.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$38.0 million, marking a year-over-year decrease of 7055.94%. This contributed to the annual value of -$12.4 million for FY2024, which is 6733.09% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Cash from Investing Activities stood at $47.2 million for Q4 2023, which was up 42470.78% from -$22.3 million recorded in Q3 2023.
  • In the past 5 years, Terns Pharmaceuticals' Cash from Investing Activities ranged from a high of $47.2 million in Q4 2023 and a low of -$96.8 million during Q1 2021
  • Over the past 4 years, Terns Pharmaceuticals' median Cash from Investing Activities value was -$671000.0 (recorded in 2020), while the average stood at -$10.8 million.
  • Over the last 5 years, Terns Pharmaceuticals' Cash from Investing Activities had its largest YoY gain of 8896000.0% in 2021, and its largest YoY loss of 2039215.69% in 2021.
  • Quarter analysis of 4 years shows Terns Pharmaceuticals' Cash from Investing Activities stood at -$47000.0 in 2020, then tumbled by 13561.7% to -$6.4 million in 2021, then crashed by 126.54% to -$14.5 million in 2022, then skyrocketed by 424.71% to $47.2 million in 2023.
  • Its Cash from Investing Activities stands at $47.2 million for Q4 2023, versus -$22.3 million for Q3 2023 and -$90.8 million for Q2 2023.